Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on: July 02,2024

Study shines light on cancer survival and a key gene mutation

by University of TorontoScientists and doctors have known about the p53 gene for a long time, and that it plays a role in halting tumour growth. Credit: Hush Naidoo via UnsplashUniversity of Toro

Updated on:July 02,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on: April 07,2024

Expert second opinion improves reliability of melanoma diagnoses

by University of California, Los AngelesCredit: CC0 Public DomainGetting a reliable diagnosis of melanoma can be a significant challenge for pathologists. The diagnosis relies on a pathologist&#3

Updated on:April 07,2024

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re

Updated on: June 24,2024

Researchers create novel compound targeting melanoma cells

by Boston University School of MedicineMelanoma in skin biopsy with H&E stain—this case may represent superficial spreading melanoma. Credit: Wikipedia/CC BY-SA 3.0An international team of re

Updated on:June 24,2024

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b

Updated on: March 01,2024

Researcher and her students discover lesser-known gene associated with breast cancer

by Villanova UniversityCredit: Villanova UniversityVillanova University biology professor Janice Knepper, PhD, and her students have discovered that a gene, previously poorly characterized, can b

Updated on:March 01,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on: May 17,2024

Doctors try CRISPR gene editing for cancer, a 1st in the US

by Marilynn MarchioneIn this January 2019 image made from video provided by Penn Medicine, IV bags of CRISPR-edited T cells are prepared for administering to a patient at the Abramson Cancer Center in

Updated on:May 17,2024

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to

Updated on: March 12,2024

Precision oncology insights revealed for colorectal cancer

by UNC Lineberger Comprehensive Cancer CenterCredit: CC0 Public DomainNext-generation sequencing of tumor DNA from patients with colorectal cancer revealed genetic alterations that were linked to

Updated on:March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on: March 12,2024

Study analyses how far people will travel for specialist cancer care

by University College LondonCredit: Keith Sergeant Source:FlickrPeople are willing to travel 75 minutes longer for specialist cancer surgery if it reduces their risk of complications

Updated on:March 12,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on: January 02,2024

Metachronous pathology assessed in young-onset colorectal cancer survivors

The incidence rate of clinically significant metachronous colorectal pathology is 32 per 1,000 person-years after index young-onset colorectal cancer (YOCRC), according to a research letter published

Updated on:January 02,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on: February 03,2024

First-line regimens with endocrine therapy show benefits in breast cancer

by Lori SolomonFirst-line regimens with endocrine therapy (ET) may be associated with benefits among patients with human epidermal growth factor receptor 2-positive (ERBB2-positive [formerly HER2-posi

Updated on:February 03,2024

Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a be

Updated on: September 28,2024

Long-course radiotherapy found to be better than short-course for organ preservation in rectal cancer

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainThe COVID-19 pandemic has enabled researchers to show that a long course of radiotherapy given before surgery may be a be

Updated on:September 28,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on: February 18,2024

Research suggests a new approach for treatment-resistant breast cancers

by Louisiana State UniversityCB-103 shows synergy with paclitaxel and fulvestrant in breast cancer cell lines. TNBC (HCC1187) and ER+ BC (MCF-7) cells were treated with combinations of CB-103 (15

Updated on:February 18,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on: February 03,2024

Team discovers broken 'brake' of cancer mutation machine

by UT Southwestern Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.06.010Loss of a gene known as SYNCRIP in prostate cancer tumors unleashes cellular machinery that

Updated on:February 03,2024